1. Disparities and inequalities of penicillin allergy in the Asia‐Pacific region.
- Author
-
Li, Philip H., Pawankar, Ruby, Thong, Bernard Y. H., Mak, Hugo W. F., Chan, Grace, Chung, Wen‐Hung, Juan, Meng, Kang, Hye‐Ryun, Kim, Byung‐Keun, Lobo, Rommel Crisenio M., Lucas, Michaela, Pham, Duy Le, Ranasinghe, Thushali, Rengganis, Iris, Rerkpattanapipat, Ticha, Sonomjamts, Munkhbayarlakh, Tsai, Yi‐Giien, Wang, Jiu‐Yao, Yamaguchi, Masao, and Yun, James
- Subjects
PENICILLIN ,ALLERGIES ,MEDICAL personnel - Abstract
On average, how many individual consultations/visits on average are patients required to attend for entire penicillin allergy delabelling process (including history taking, allergy testing, provocation testing etc.)
a. If your centre performs penicillin skin prick/intradermal testing, which reagents do you routinely include in your penicillin allergy workup? The overwhelming burden of penicillin "allergy" labels remains a global public health concern associated with a myriad of adverse clinical outcomes.[1] The epidemiology and sensitization patterns of penicillin allergy varies greatly and remain largely unknown in the Asia-Pacific (AP) region.[[2], [4]] This international survey was performed to investigate the epidemiology, healthcare infrastructures and clinical practices pertaining to penicillin allergy in AP. In addition to penicillin allergy labels, what proportion (%) of patients have other drug allergy labels?. [Extracted from the article] - Published
- 2023
- Full Text
- View/download PDF
2. Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity.
- Author
-
Torres, María José, Trautmann, Axel, Böhm, Ingrid, Scherer, Kathrin, Barbaud, Annick, Bavbek, Sevim, Bonadonna, Patrizia, Cernadas, Josefina Rodrigues, Chiriac, Anca Mirela, Gaeta, Francesco, Gimenez‐Arnau, Ana M., Kang, Hye‐Ryun, Moreno, Esther, and Brockow, Knut
- Subjects
CONTRAST media ,ALLERGIES ,DIAGNOSIS ,RISK assessment ,CLINICAL drug trials - Abstract
Immediate and nonimmediate hypersensitivity reactions to iodinated contrast media (ICM) have been reported to occur in a frequency of about 0.5%‐3% of patients receiving nonionic ICM. The diagnosis and management of these patients vary among guidelines published by various national and international scientific societies, with recommendations ranging from avoidance or premedication to drug provocation test. This position paper aims to give recommendations for the management of patients with ICM hypersensitivity reactions and analyze controversies in this area. Skin tests are recommended as the initial step for diagnosing patients with immediate and nonimmediate hypersensitivity reactions; besides, they may also help guide on tolerability of alternatives. Re‐exposition or drug provocation test should only be done with skin test‐negative ICMs. The decision for performing either re‐exposition or drug provocation test needs to be taken based on a risk‐benefit analysis. The role of in vitro tests for diagnosis and pretreatment for preventing reactions remains controversial. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Books, media, physical & digital resourcesDiscovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.